Page last updated: 2024-08-21

pyrazines and Leiomyomatosis

pyrazines has been researched along with Leiomyomatosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Giubellino, A; Linehan, WM; Neckers, L; Sourbier, C; Sudarshan, S; Valera-Romero, V; Yang, Y	1

Other Studies

1 other study(ies) available for pyrazines and Leiomyomatosis

Article	Year
Increasing reactive oxygen species as a therapeutic approach to treat hereditary leiomyomatosis and renal cell carcinoma. Cell cycle (Georgetown, Tex.), 2010, Oct-15, Volume: 9, Issue:20 Topics: Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Carcinoma, Renal Cell; Cell Death; Cell Line, Tumor; Cisplatin; Humans; Kidney Neoplasms; Leiomyomatosis; Mice; Mice, SCID; Neoplasm Transplantation; Pyrazines; Reactive Oxygen Species; Transplantation, Heterologous	2010

Article

Year

Increasing reactive oxygen species as a therapeutic approach to treat hereditary leiomyomatosis and renal cell carcinoma.

Cell cycle (Georgetown, Tex.), 2010, Oct-15, Volume: 9, Issue:20

Topics: Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Carcinoma, Renal Cell; Cell Death; Cell Line, Tumor; Cisplatin; Humans; Kidney Neoplasms; Leiomyomatosis; Mice; Mice, SCID; Neoplasm Transplantation; Pyrazines; Reactive Oxygen Species; Transplantation, Heterologous

2010